Market Place
Sourcing Support
All News #Library
Biotech
Veracyte Showcases Extensive Decipher Data At 2026 ASCO GU
24 Feb 2026 //
BUSINESSWIRE
Veracyte Introduces Afirma GRID For Advanced Thyroid Nodule
03 Nov 2025 //
BUSINESSWIRE
Veracyte To Present Hormone Therapy Biomarker Validation Data
24 Sep 2025 //
BUSINESSWIRE
Veracyte Announces New Study Published Metastatic Prostate Cancer
27 Aug 2025 //
BUSINESSWIRE
Veracyte`s Afirma GRID Studies to Be Presented at ENDO 2025
08 Jul 2025 //
BUSINESSWIRE
Veracyte links Decipher Prostate results to SEER Database
21 Apr 2025 //
BUSINESSWIRE
Veracyte`s Afirma GRID Suggests Thyroid Tumor Molecular Testing Prognosis
03 Jun 2024 //
BUSINESSWIRE
Veracyte Completes Acquisition of C2i Genomics
06 Feb 2024 //
BUSINESSWIRE
Veracyte to buy C2i Genomics for up to $95M, includes $70M upfront
08 Jan 2024 //
ENDPTS
Veracyte Announces Novel Afirma-Based Findings of Thyroid Cancer to Be Presented
21 Sep 2023 //
BUSINESSWIRE
Veracyte Announces Data Suggesting Afirma Testing Can Help Personalize Care for Patients with Thyroid Nodules
01 Feb 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.